ERBB2 and breast carcinoma: According to bc-GenExMiner v4.3, estrogen receptor or progesterone receptor-positive (IHC) breast cancer patients were with higher PTPRT levels, while HER2+ (IHC) breast cancer patients were with lower PTPRT level.